CD163 and small cell lung carcinoma: We analyzed the relationship between tumor‐infiltrating immune cells (CD4, CD8, FOXP3, CD163‐positive cells) and proteins (TGFβ1 and its downstream signal, SMAD3) expression and survival after the start of combined therapy with immune checkpoint inhibitors plus chemotherapy in SCLC.